Search results
Dana-Farber Cancer Institute in Boston, MA, is a world leader in adult and pediatric cancer treatment and research. Our oncologists and cancer researchers practice and develop some of the most advanced cancer treatments in the world.
Since 1947, Dana-Farber Cancer Institute has been providing expert cancer care and groundbreaking treatments for adult and pediatric patients. U.S. News and World Report consistently ranks Dana-Farber as the #1 cancer hospital in New England, and among the best in the nation.
The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community.
Since its founding in 1947, Dana-Farber Cancer Institute in Boston, Massachusetts has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research.
Main: (617) 632-3000. Spanish Speakers: (617) 632-3673. Visit Website. Dana-Farber/Harvard Cancer Center (DF/HCC) is a collaboration between academic institutions, world-renowned for its leadership in adult and pediatric cancer treatment and research.
May 24, 2021 · Cancer vaccines are a form of immunotherapy aimed at enhancing the immune system’s ability to recognize and attack cancer cells, or to protect against certain forms of cancer caused by viruses.
Dana-Farber Cancer Institute has two main campuses. One is located in Boston's Longwood Medical Area and provides care for adult and pediatric cancer patients. The other campus is located in Chestnut Hill, MA and provides care for adult cancer patients.
